Clinical

Dataset Information

0

Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research


ABSTRACT: The patients with non-resectable colorectal liver metastases (CRLM) have always being considered a particular subgroup of CRLM in which the therapeutic approach, is focused on strategies that allow a potential surgery like neoadjuvant systemic treatments. But, the underlying biology that causes this particular profile of spread in a proportion of patients that always recur and progress in the liver has not been properly characterized from a biological point of view. Unfortunately, these patients finally develop liver metastasis not amenable for local treatments and become refractory to systemic treatments even without developing extrahepatic liver metastases. As a result, liver transplantation (LT) is a potential for patients without extrahepatic involvement and nonresectable CRLM. There are several studies that aims to evaluate if LT increases overall survival compared to best alternative care. To our knowledge, none of these studies incorporate objectives focused on the underlying tumor biology of this particular population and the development of focused strategies including a dynamic disease monitoring and targeted treatments for this particular population.The METLIVER trial will permit to expand the genetic studies to the whole complexity of metastatic lesions and a more precise evaluation of their genetic heterogeneity. Moreover, it will help to precise the type of genetic analyses on liquid biopsies that can be designed for patients that will unfortunately relapse mostly with lung metastases after LT. Our proposal will maximize the opportunity to produce an unprecedented knowledge on CRLM evolution and will provide new opportunities for relapsed patients.

DISEASE(S): Neoplasm Metastasis,Genetic Change,Liver Metastases,Colorectal Cancer,Liver Neoplasms

PROVIDER: 2732685 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2020-09-16 | PXD015015 | Pride
2023-09-17 | GSE243245 | GEO
2023-06-19 | GSE235057 | GEO
2018-11-21 | PXD008383 | Pride
2012-03-01 | E-GEOD-32384 | biostudies-arrayexpress
2023-05-16 | GSE206552 | GEO
2024-08-23 | GSE262705 | GEO
2024-08-23 | GSE267196 | GEO
2019-11-30 | GSE125404 | GEO
| 2742045 | ecrin-mdr-crc